VRTX - VERTEX PHARMACEUTICALS INC / MA

QQQ $ 442.84 $ -0.57 (-0.13 %)

DIA $ 394.52 $ -0.72 (-0.18 %)

SPY $ 520.61 $ -0.23 (-0.04 %)

TLT $ 90.36 $ 0.25 (0.28 %)

GLD $ 216.28 $ -2.43 (-1.11 %)

Previous Close

$ 429.93

Open

$ 424.84

Bid

$ 0.00 x 0

Ask

$ 430.13 x 100

Day's Range

$ 424.79 - $ 430.52

52 Week Range

$ 320.01 - $ 448.40

Volume

1,064,604

Average Volume

Market Cap

110.39B

Beta (5Y Monthly)

$ 0.50

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2024	03-31-2024	10-Q
2	02-15-2024	12-31-2023	10-K
3	11-07-2023	09-30-2023	10-Q
4	08-02-2023	06-30-2023	10-Q
5	05-02-2023	03-31-2023	10-Q
6	02-10-2023	12-31-2022	10-K
7	10-28-2022	09-30-2022	10-Q
8	08-05-2022	06-30-2022	10-Q
9	05-06-2022	03-31-2022	10-Q
10	02-09-2022	12-31-2021	10-K
11	11-03-2021	09-30-2021	10-Q
12	07-30-2021	06-30-2021	10-Q
13	04-30-2021	03-31-2021	10-Q
14	02-11-2021	12-31-2020	10-K
15	10-30-2020	09-30-2020	10-Q
16	07-31-2020	06-30-2020	10-Q
17	05-01-2020	03-31-2020	10-Q
18	02-13-2020	12-31-2019	10-K
19	10-31-2019	09-30-2019	10-Q
20	08-01-2019	06-30-2019	10-Q
21	05-01-2019	03-31-2019	10-Q
22	02-13-2019	12-31-2018	10-K
23	10-25-2018	09-30-2018	10-Q
24	07-26-2018	06-30-2018	10-Q
25	04-27-2018	03-31-2018	10-Q
26	02-15-2018	12-31-2017	10-K
27	10-30-2017	09-30-2017	10-Q
28	07-28-2017	06-30-2017	10-Q
29	04-28-2017	03-31-2017	10-Q
30	02-23-2017	12-31-2016	10-K
31	10-31-2016	09-30-2016	10-Q
32	08-01-2016	06-30-2016	10-Q
33	05-03-2016	03-31-2016	10-Q
34	02-16-2016	12-31-2015	10-K
35	10-30-2015	09-30-2015	10-Q
36	08-04-2015	06-30-2015	10-Q
37	05-04-2015	03-31-2015	10-Q
38	02-13-2015	12-31-2014	10-K
39	11-06-2014	09-30-2014	10-Q
40	07-31-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

a-closer-look-at-vertex-pharmaceuticalss-options-market-dynamics

A Closer Look at Vertex Pharmaceuticals's ...
05/08/2024 18:45:46

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
05/07/2024 17:35:23

us-stocks-eye-fourth-positive-session-despite-hawkish-fed-remarks-disney-palantir-tumble-treasury-yields-fall-whats-driving-markets-tuesday

US Stocks Eye Fourth Positive Session Desp...
05/07/2024 17:18:32

Wall Street experienced a quiet session during morning trading on Tuesday, influenced by a lack of significant economic data an...

RBC Capital Maintains Sector Perform on Ve...
05/07/2024 15:03:05

RBC Capital analyst Brian Abrahams maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Sector Perform and raises the price...

HC Wainwright & Co. Reiterates Buy on Vert...
05/07/2024 11:45:45

HC Wainwright & Co. analyst Andrew Fein reiterates Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and maintains $462 pr...

Needham Reiterates Hold on Vertex Pharmace...
05/07/2024 11:27:31

Needham analyst Joseph Stringer reiterates Vertex Pharmaceuticals (NASDAQ:VRTX) with a Hold.

Piper Sandler Maintains Overweight on Vert...
05/07/2024 11:16:55

Piper Sandler analyst Christopher Raymond maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overweight and raises the pr...

Vertex Reiterates FY24 Financial Guidance,...
05/06/2024 20:26:05

Vertex's product revenue guidance includes expectations for continued growth in CF as well as for the launch of CASGEVY in ...

Vertex Pharmaceuticals Q1 2024 Adj EPS $4....
05/06/2024 20:05:28

Vertex Pharmaceuticals (NASDAQ:VRTX) reported quarterly earnings of $4.76 per share which beat the analyst consensus estimate o...

Smart Money Is Betting Big In VRTX Options
05/06/2024 16:15:50

heres-how-much-you-would-have-made-owning-vertex-pharmaceuticals-stock-in-the-last-10-years

Here's How Much You Would Have Made Owning...
05/02/2024 16:00:22

100b-vertex-pharma-working-to-recreate-10b-cystic-fibrosis-success---this-time-focused-on-pain-management-drugs

$100B Vertex Pharma Working To Recreate $1...
04/26/2024 18:34:08

Unlock Vertex Pharmaceuticals' pioneering treatments, from the groundbreaking Trikafta for cystic fibrosis to the promising...

Vertex Announces European Commission Appro...
04/26/2024 15:57:28

- Reuters

vrtx---analyzing-vertex-pharmaceuticalss-short-interest

(VRTX) - Analyzing Vertex Pharmaceuticals'...
04/25/2024 18:30:18

Vertex Announce Licensing Agreement And Co...
04/23/2024 05:37:19

Vertex obtains an exclusive license to TreeFrog's C-StemTM manufacturing technology in type 1 diabetes TreeFrog and Ve...

Tesla To $123? Here Are 10 Top Analyst For...
04/18/2024 12:46:42

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

Vertex Pharmaceuticals Announced Advanceme...
04/18/2024 12:05:48

Rolling submission for suzetrigine moderate-to-severe acute pain NDA granted by FDA; first module submitted and on track to c...

Guggenheim Maintains Buy on Vertex Pharmac...
04/18/2024 11:44:58

Guggenheim analyst Debjit Chattopadhyay maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price targe...

if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-6000-today

If You Invested $1000 In This Stock 10 Yea...
04/16/2024 16:00:35

Oppenheimer Maintains Outperform on Vertex...
04/15/2024 11:53:25

Oppenheimer analyst Hartaj Singh maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Outperform and maintains $500 price t...